On 26 May, the EU funded research project ENBEL (Enhancing Belmont Research Action to support EU policy making on climate change and health), of which HEAL is a partner, organises an event entitled Novel climate change and health research.
A review of the EU assessment report from the Health and Environment Alliance (HEAL) on the toxicity of the popular pesticide glyphosate confirms that the evaluation is still mostly based on studies and arguments provided by the chemical industry and does not take into consideration all available scientific evidence .
The assessment report, which details how EU institutions and member states plan to evaluate the toxicity of glyphosate, was published in the framework of the two public consultations launched by the EU Chemicals Agency (ECHA) and the EU Food Safety Authority (EFSA) that closed last Monday. The market license of glyphosate expires on 15 December 2022.
Following the submission of no less than 53 comments, HEAL expresses its disappointment with the assessment as it does not reflect the evidence from independent scientific studies. For example, the document does not report how glyphosate can cause DNA damage, nor does it account for the evidence exposing scientific misconduct committed by companies in the interpretation of the results of cancer and epidemiology studies . HEAL also provided comments in relation to the reported impacts of glyphosate on female and male reproduction and endocrine disruption.
In fact, HEAL’s analysis identifies exactly the same systematic errors as those made in the previous renewal process of the pesticide: health impacts reported in public scientific literature were discredited or underrated, and those detected in industry studies were repeatedly considered to be irrelevant, without scientific justification .
In an open letter sent to EU Health Commissioner Stella Kyriakides last month, 41 health and environment groups from across Europe already expressed their concerns about the use of unreliable industry studies in the current renewal assessment of glyphosate . In her response, the EU Commissioner maintains that the ongoing assessment of glyphosate takes into consideration all available scientific evidence from peer-reviewed independent literature . However, HEAL’s analysis of the current assessment report puts question marks next to this statement.
Angeliki Lyssimachou, HEAL’s Senior Science Policy Officer, explains: “The EU Health Commissioner insists that the assessment is not solely based on industry sponsored studies and includes all relevant available peer-reviewed open literature. However, this is not the case. Scientific evidence from independent literature reporting adverse effects caused by glyphosate, or errors in the assessment procedure, are too often considered irrelevant or unreliable for the assessment.”
HEAL calls on the institutions and member states in charge of the EU assessment of the toxicity of glyphosate to scrutinize objectively all the available scientific evidence and endorse the independent literature findings in the assessment, which clearly show the potential of glyphosate to cause cancer and that it is dangerous for human health.